skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Search For:
Clear Search Box
Search in:
Busca Geral
Or select another collection:
Search in:
Busca Geral
Busca Avançada
Busca por Índices
This feature requires javascript
Tipo de recurso
criteria input
qualquer lugar do registro
no título
como autor
no assunto
Data de publicação
lsr01
lsr02
lsr03
lsr04
Orientador
Show Results with:
no título
Show Results with:
qualquer lugar do registro
no título
como autor
no assunto
Data de publicação
lsr01
lsr02
lsr03
lsr04
Orientador
Mostra resultados com:
criteria input
que contêm minhas palavras de busca
com a frase exata
começa com
Mostra resultados com:
Índice
criteria input
E
OU
NÃO
This feature requires javascript
Opsoclonus myoclonus ataxia syndrome in Israel
Blumkin, Lubov ; Lerman-Sagie, Tally
הרפואה, 2010-01, Vol.149 (1), p.24-63
Israel
Texto completo disponível
Citações
Citado por
Exibir Online
Detalhes
Resenhas & Tags
Mais Opções
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
Opsoclonus myoclonus ataxia syndrome in Israel
Autor:
Blumkin, Lubov
;
Lerman-Sagie, Tally
Assuntos:
Adrenocorticotropic Hormone - therapeutic use
;
Antibodies, Monoclonal - therapeutic use
;
Antibodies, Monoclonal, Murine-Derived
;
Child, Preschool
;
Developmental Disabilities - etiology
;
Developmental Disabilities - rehabilitation
;
Humans
;
Immunoglobulins - therapeutic use
;
Immunologic Factors - therapeutic use
;
Immunophenotyping
;
Infant
;
Lymphocytes - immunology
;
Lymphocytes - pathology
;
Male
;
Neuroblastoma - diagnosis
;
Opsoclonus-Myoclonus Syndrome - complications
;
Opsoclonus-Myoclonus Syndrome - diagnosis
;
Opsoclonus-Myoclonus Syndrome - immunology
;
Opsoclonus-Myoclonus Syndrome - therapy
;
Rituximab
É parte de:
הרפואה, 2010-01, Vol.149 (1), p.24-63
Notas:
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Descrição:
Opsoclonus-myoclonus-ataxia (OMS) is a rare, autoimmune, neurobehavioral syndrome that presents with a movement disorder, developmental regression, behavior disorder and cognitive decline. The syndrome is more prevalent in the first two years of life but can also affect adults. The diagnosis is based on the combination of clinical signs and assessment of the cerebrospinal fluid (CSF) for subtypes of T and B lymphocytes. Since it is a paraneoplastic disorder in 50% of cases, it is imperative to search for a neural crest tumor. The treatment is complex and prolonged and the prognosis depends on early diagnosis and full treatment. Description of the experience of the Pediatric Movement Disorder Service at Wolfson Medical Center in the diagnosis and treatment of opsoclonus-myoclonus-ataxia syndrome. The files of all the patients who were evaluated for OMS in the last 4 years were reviewed. Five of ten patients were diagnosed and treated. The age at presentation was 5 to 20 months. In 4 children the diagnosis was delayed beyond 3 months. All the patients were males. A neuroblastoma was found in one patient. Four children had behavioral and sleep disturbances which necessitated treatment. All the children were treated with adrenocorticotropic hormone (ACTH) and immunoglobulins. CSF lymphocyte immunophenotyping was pathologic in 4 patients and they were treated with rituximab. All the children showed developmental delay and received rehabilitation. Two children completed the treatment. The child who received early treatment shows normal development. The other has language delay. Although opsoclonus-myoclonus-ataxia is a rare disorder, it is necessary to increase the physicians' awareness of this syndrome in order to enable early diagnosis and treatment.
Editor:
Israel
Idioma:
Hebraico
Links
View this record in MEDLINE/PubMed
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_PRODUCAO),scope:(USP_EBOOKS),scope:("PRIMO"),scope:(USP),scope:(USP_EREVISTAS),scope:(USP_FISICO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript